» Articles » PMID: 38393604

Prominent Genetic Variants and Epigenetic Changes in Post-traumatic Stress Disorder Among Combat Veterans

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2024 Feb 23
PMID 38393604
Authors
Affiliations
Soon will be listed here.
Abstract

Post-traumatic stress disorder (PTSD) is one of the most widespread and disabling psychiatric disorders among combat veterans. Substantial interindividual variability in susceptibility to PTSD suggests the presence of different risk factors for this disorder. Twin and family studies confirm genetic factors as important risk factors for PTSD. In addition to genetic factors, epigenetic factors, especially DNA methylation, can be considered as a potential mechanism in changing the risk of PTSD. So far, many genetic and epigenetic association studies have been conducted in relation to PTSD. In genetic studies, many single nucleotide polymorphisms have been identified as PTSD risk factors. Meanwhile, the variations in catecholamines-related genes, serotonin transporter and receptors, brain-derived neurotrophic factor, inflammatory factors, and apolipoprotein E are the most prominent candidates. CpG methylation in the upstream regions of many genes is also considered a PTSD risk factor. Accurate identification of genetic and epigenetic changes associated with PTSD can lead to the presentation of suitable biomarkers for susceptible individuals to this disorder. This study aimed to delineate prominent genetic variations and epigenetic changes associated with post-traumatic stress disorder in military veterans who have experienced combat, focusing on genetic and epigenetic association studies.

References
1.
Javidi H, Yadollahie M . Post-traumatic Stress Disorder. Int J Occup Environ Med. 2012; 3(1):2-9. View

2.
Kessler R, Wang P . The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health. 2008; 29:115-29. DOI: 10.1146/annurev.publhealth.29.020907.090847. View

3.
Michopoulos V, Rothbaum A, Jovanovic T, Almli L, Bradley B, Rothbaum B . Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. Am J Psychiatry. 2015; 172(4):353-62. PMC: 4440454. DOI: 10.1176/appi.ajp.2014.14020263. View

4.
Rosenbaum S, Stubbs B, Ward P, Steel Z, Lederman O, Vancampfort D . The prevalence and risk of metabolic syndrome and its components among people with posttraumatic stress disorder: a systematic review and meta-analysis. Metabolism. 2015; 64(8):926-33. DOI: 10.1016/j.metabol.2015.04.009. View

5.
Kessler R . Posttraumatic stress disorder: the burden to the individual and to society. J Clin Psychiatry. 2000; 61 Suppl 5:4-12; discussion 13-4. View